Category: Healthcare Finance News

National healthcare spending growth slowed in 2017, CMS says

One reason is the decrease in spending on prescription drugs, from fewer opioids being dispensed to a drop in treatment for hepatitis C.

Want to increase your hospital’s operational efficiency and cohesiveness? Huddle up, says Intermountain Healthcare’s CEO

Marc Harrison said the escalation process, which includes daily huddles with all levels of staff, has provided operational clarity, improved safety.

Struggles will continue for nonprofit hospitals in 2019, Fitch says

The downcast outlook is due largely to ongoing operational weaknesses, which have evolved into a fundamental shift in the sector.

American Hospital Association among those suing HHS over site neutral payments

The hospitals that rely on Medicare payments may have to cut services due to the $380 million payment reduction, the lawsuit says.

Telemedicine use for treating substance use disorder remains low, despite unmet need

Despite an increase in usage, telehealth visits for substance use disorder represented just 1.4 percent of telehealth visits for any health condition.

Kaiser Permanente commits $1.65 million to California wildfire relief efforts

The money will be paid out through multiple gifts to various charitable organizations and system also has dispatched medical personnel to assist those in shelters.

CVS Health, Aetna should integrate while federal court decision is pending, Justice Department says

The DOJ is going against the opinion of federal judge who wants CVS Health and Aetna assets to remain separate.

What growing demand for physicians means to top hospital executives

The spike in physician jobs is outpacing the strong economy, and that means it’s time for hospitals to prepare for even fewer doctors to choose from.

Hospital merger and acquisition pitfalls to avoid

In Part 2 of our series on the hospital mergers, a look at the common problems and advice about how to sidestep them.

CVS Health’s new guaranteed net pricing PBM returns 100% of rebates to health plan clients

New model offers drug cost predictability; PBM takes accountability for impact of drug price inflation and shifts in drug mix.